The Xlife Sciences AG company focuses on value creation and commercialization of promising research projects from universities in the life sciences sector. In particular, the focus is on the development and commercialization of technologies in the areas of biotechnology, therapies, medical technology and artificial intelligence. The company invests in projects in the proof-of-concept phase and aims to generate profits through diversification of the portfolio in various core areas of the life sciences industry.